Daily Cosmetic Research Analysis
Three studies with direct relevance to cosmetics and aesthetic surgery stood out today: a large analytical survey from India quantified volatile methylsiloxanes in 174 personal care products; an ex vivo human-skin study showed ablative fractional lasers outperform needle-based devices for delivering poly-L-lactic acid; and a PRISMA-compliant systematic review supported tranexamic acid to reduce bleeding-related morbidity in face/neck lifts.
Summary
Three studies with direct relevance to cosmetics and aesthetic surgery stood out today: a large analytical survey from India quantified volatile methylsiloxanes in 174 personal care products; an ex vivo human-skin study showed ablative fractional lasers outperform needle-based devices for delivering poly-L-lactic acid; and a PRISMA-compliant systematic review supported tranexamic acid to reduce bleeding-related morbidity in face/neck lifts.
Research Themes
- Chemical safety and exposure from personal care products
- Device-mediated dermal drug delivery in aesthetic dermatology
- Perioperative hemostasis optimization in facial plastic surgery
Selected Articles
1. Volatile methylsiloxanes in beauty and personal care products sold in India and human exposure assessment.
Analyzing 174 personal care products in India, the authors detected volatile methylsiloxanes in all samples, with detection frequencies ranging from 20% to 99%. Cyclic species, especially D5 and D6, predominated, and total cyclic concentrations reached as high as 773,000 μg g. These data provide a substantial exposure-relevant dataset for regulators and formulators.
Impact: Provides one of the largest product-level datasets on volatile methylsiloxanes in a major market, informing exposure assessment and potential regulatory action for cosmetics and personal care.
Clinical Implications: While not a clinical trial, these findings support clinician counseling on product selection for environmentally conscious or sensitive patients and underscore the need for policy-driven exposure reduction.
Key Findings
- Volatile methylsiloxanes were detected in all 174 Indian personal care products tested, with detection frequencies from 20% to 99%.
- Cyclic VMS, especially D5 (decamethylcyclopentasiloxane) and D6 (dodecamethylcyclohexasiloxane), predominated across samples.
- Total cyclic siloxane concentrations reached as high as 773,000 μg g in some products.
Methodological Strengths
- Large sample of 174 market-available products spanning cyclic and linear VMS.
- Quantitative detection with reporting of detection frequencies and predominant species.
Limitations
- Abstract does not report biomonitoring data or detailed human exposure estimates.
- Cross-sectional product survey limited to the Indian market; health outcomes not assessed.
Future Directions: Link product concentrations to modeled and biomonitored human exposures; evaluate health and environmental outcomes; assess effectiveness of regulatory limits in reducing VMS burden.
This study investigated the presence of cyclic and linear volatile methylsiloxanes in 174 beauty and personal care products (PCPs) sold in India. Siloxanes were detected in all the samples with a detection frequency of 20 to 99 %. The cyclic siloxanes viz. decamethylcyclopentasiloxane (D5) and dodecamethylcyclohexasiloxane (D6) were predominant in all the samples, and the total concentration of cyclic siloxanes was as high as 773,000 μg g
2. Ablative Fractional Lasers Versus Needle-Based Devices for Poly- l -Lactic Acid Delivery: An Optical Coherence Tomography and Histology Study.
In ex vivo full-thickness human skin, ablative fractional lasers enabled significant PLLA uptake visualized by real-time OCT and confirmed histologically, whereas microneedle RF and microneedles showed minimal uptake. CO2 laser channels supported deeper delivery (120–240 μm) and DFG laser more superficial delivery (0–120 μm), indicating channel geometry can tune vertical distribution.
Impact: Demonstrates a mechanistically grounded, device-specific strategy for topical PLLA delivery, potentially shifting practice away from needle-based approaches toward laser-assisted delivery with tunable depth.
Clinical Implications: For aesthetic dermatology, AFLs may be preferred for topical PLLA delivery, with CO2 vs DFG selection based on desired depth. Clinical protocols should await in vivo retention and remodeling data.
Key Findings
- Real-time OCT showed PLLA particles descending into channels created by AFLs, but not by MNRF or microneedles.
- Histology confirmed PLLA uptake in up to 80.3% of CO2 laser channels and 61.9% of DFG laser channels versus minimal uptake with MNRF (1.4%) and MN (0.7%).
- CO2 laser achieved deeper delivery (120–240 μm), whereas DFG laser provided more superficial delivery (0–120 μm).
Methodological Strengths
- Combined real-time OCT with histological validation in full-thickness human skin.
- Direct head-to-head comparison of multiple devices with quantitative uptake metrics.
Limitations
- Ex vivo study; in vivo retention, safety, and clinical remodeling outcomes remain unknown.
- Single-tissue source and limited channel parameter space may constrain generalizability.
Future Directions: Conduct in vivo trials to quantify PLLA retention, remodeling outcomes, and safety; optimize laser parameters and particle formulations for targeted depth delivery.
BACKGROUND: Poly- l -lactic acid (PLLA) is widely used in dermatology, traditionally through subcutaneous injections. Alternative delivery methods such as ablative fractional lasers (AFLs) and needle-based devices have gained interest, but limited data exist on their efficacy. OBJECTIVE: To assess the effectiveness of AFLs and needle-based devices for PLLA delivery and the impact of channel morphology on PLLA uptake. METHODS: Full-thickness human abdominal skin samples were treated with fractional CO 2 laser, fractional difference frequency generation (DFG) laser, fractional microneedle radiofrequency (MNRF), and microneedle (MN). After applying PLLA topically, real-time particle movement into the channels was detected through optical coherence tomography (OCT). Histology assessed the vertical distribution of PLLA. RESULTS: Optical coherence tomography captured PLLA particles descending into channels from AFLs, but not MNRF or MN. Histology confirmed PLLA uptake in up to 80.3% of CO 2 channels and 61.9% of DFG channels, compared with minimal uptake with MNRF (1.4%) and MN (0.7%). The CO 2 laser enabled deeper penetration (120-240 μm), whereas the DFG laser delivered more superficially (0-120 μm). CONCLUSION: Ablative fractional lasers effectively delivered PLLA through the skin, while needle-based devices showed minimal uptake. Among AFLs, channel geometry influenced vertical particle distribution. In vivo and clinical studies are needed to assess PLLA retention and its impact on remodeling.
3. Evaluation of the safety and efficacy of tranexamic acid use in face and neck lift surgery: A systematic review.
Across 10 studies with 592 patients, tranexamic acid in face/neck lifts was associated with reduced intraoperative blood loss (3 studies), lower hematoma rates (4/6 studies), less ecchymosis, and decreased drain output/time to removal in 5 studies, without increased infections. Effects were seen across topical, local, tumescent, and IV routes, though heterogeneity remains.
Impact: Synthesizes heterogeneous but convergent evidence that TXA improves perioperative outcomes in aesthetic facial surgery, informing protocols and shared decision-making.
Clinical Implications: Consider TXA to reduce bleeding, hematoma, ecchymosis, and drain burden in face/neck lifts; individualize route/dose and monitor for wound-related complications.
Key Findings
- Ten studies (592 patients; mean age 62 years; 90% women) evaluated TXA via topical, local injection, tumescent admixture, or IV routes.
- TXA reduced intraoperative blood loss in 3 studies and hematoma incidence in 4 of 6 studies.
- Significant reductions in ecchymosis and shorter duration, decreased postoperative edema in 1 of 2 studies, and reduced drain output/time to removal in 5 studies; no increase in infections.
Methodological Strengths
- PRISMA-guided systematic review across multiple databases.
- Assessed multiple administration routes, broadening external validity.
Limitations
- Heterogeneity in dosing, routes, and outcome measures; limited randomized evidence.
- Some outcomes were not statistically significant; potential publication bias.
Future Directions: Prospective, randomized trials comparing TXA routes/doses with standardized hematoma/ecchymosis endpoints and wound complication monitoring.
INTRODUCTION: Tranexamic acid (TXA) has been used in various surgical settings to reduce bleeding and improve patient outcomes; however, its efficacy in face and neck lift is underexplored. METHODS: Following the PRISMA guidelines, this systematic review identified articles from 4 databases up to October 4, 2024, aiming to assess the efficacy of TXA in reducing the complications in patients undergoing face and/or neck lift. RESULTS: Ten articles were included. A total of 592 patients underwent either face or neck lift with TXA administration, among them 534 (90%) were women with a mean age of 62.0 years. TXA dosage ranged from 1 to 25 mg/mL topically and 1 g IV and was administered topically (4 studies), with local injection (5 studies), mixed with tumescence solution (3 studies), or intravenously (4 studies). Three studies showed evidence of reduced intraoperative blood loss with TXA. TXA reduced hematoma incidence in 4 of the 6 studies. Significant reductions in ecchymosis and shorter postoperative ecchymosis duration were reported. Skin flap complications were reported, but none were statistically significant (p > 0.05). TXA significantly reduced postoperative edema in 1 of 2 studies (p < 0.05). Procedure time was either unchanged or reduced. Drainage output and days before drain removal was reduced with TXA in 5 studies. There was no difference in the incidence of infection between groups. CONCLUSION: TXA demonstrated promising results in facial surgery by reducing intraoperative bleeding and time, postoperative ecchymosis, edema, and drain output. Although TXA did not increase systemic complications, some wound-related complications were reported.